# Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)

> **NCT07211035** · NA · NOT_YET_RECRUITING · sponsor: **Amplifi Vascular, Inc.** · enrollment: 120 (estimated)

## Conditions studied

- End Stage Kidney Disease (ESRD)

## Interventions

- **DEVICE:** The Amplifi System is a temporary extracorporeal blood pump designed to deliver controlled flow through a peripheral vein for 24-72 hours prior to AVF creation.
- **PROCEDURE:** Standard of Care (AVF creation)

## Key facts

- **NCT ID:** NCT07211035
- **Lead sponsor:** Amplifi Vascular, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211035, "Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07211035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*